OSN [Ossen Innovation] 6-K: Ossen Innovation’s Chairman Recognized as a Top Philanthropist

[Ossen Innovation’s Chairman Recognized as a Top Philanthropist in China SHANGHAI, May 5, 2011 -- Ossen Innovation Co., Ltd. ("Ossen" or the "Company") (NASDAQ: OSN), a China-based manufacturer primarily engaged in manufacturing of galvanized pre-stressed steel wires used in the production of bridge cables, today announced that Dr. Liang Tang, Chairman of the Company, was recognized as one of the] [OSSEN INNOVATION CO., LTD. Wei Hua Chief Executive Officer]

STV [China Digital TV] 6-K: China Digital TV Announces Date for Second Dividend

[China Digital TV Announces Date for Second Dividend Installment China Digital TV Holding Co., Ltd. (NYSE: STV) (“China Digital TV” or the “Company”), the leading provider of conditional access (“CA”) systems to China’s expanding digital television market, today announced that BEIJING, China, May 06, 2011 — a special cash dividend of US$2.00 per share on the Company’s ordinary shares, par] [FORM 6-K China Digital TV Holding Co., Ltd. th Jingmeng High-Tech Building B, 4 No. 5 Shangdi East Road Haidian District, Beijing 100085 People’s Republic of China x o Form 20-F o x Yes Page 99.1 Press release, dated May 06, 2011 4 CHINA DIGITAL TV HOLDING CO., LTD.]

By | 2016-03-14T06:27:08+00:00 May 6th, 2011|Categories: Chinese Stocks, STV, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q/A: FORM 10-Q/A (Amendment No. 1) (Mark One) For

[FORM 10-Q/A (Amendment No. 1) (Mark One) For the quarterly period ended: September 30, 2010 For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) People’s Republic of China No. 14 East Hushan Road (+86) 538-620-2306 ________________________________________________________________ (Former name, former address and former fiscal year,] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Chao Ming Zhao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Y. Tristan Kuo Chief Financial Officer (Principal Financial Officer)]

ONP [Orient Paper] 8-K: (Original Filing)

[CCG Investor Relations Crocker Coulson, President Tel: +1-646-213-1915 crocker.coulson@ccgir.com Email: Orient Paper, Inc. Winston Yen, Chief Financial Officer Phone: +1-562-818-3817 info@orientpaperinc.com Email: Orient Paper Announces Unaudited Preliminary Results for First Quarter Fiscal Year 2011 BAODING, Hebei, China, May 2, 2011 For the three months ended March 31, 2011, the Company is expecting to report total unaudited revenue increased 25.6% to] [CCG Investor Relations Crocker Coulson, President Tel: +1-646-213-1915 crocker.coulson@ccgir.com Email: Orient Paper, Inc. Winston Yen, Chief Financial Officer Phone: +1-562-818-3817 info@orientpaperinc.com Email: Orient Paper Schedules Conference Call to Discuss 2011 First Quarter Results BAODING, Hebei, China, May 5, 2011 To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call] [Item 2.02. Results of Operations and Financial Condition. Item 8.01.]

CBPO [China Biologic Products] 10-Q/A: (Original Filing)

[FORM 10-Q /A (Amendment No. 1) For the quarterly period ended: June 30, 2010 For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. (Name of Small Business Issuer in Its Charter) DELAWARE 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) No. 14 East Hushan Road, Taian City, Shandong People’s Republic of China 271000] [SUBSIDIARIES China Biologic Products Inc. is the parent. The subsidiaries of China Biologic Products Inc. are as follows: Jurisdiction of Ownership Interest Name Incorporation or Held By Organization The Company Logic Express Ltd BVI 100.00% Logic Holdings (Hong Kong) Ltd HK 100.00% Logic Management Consulting (China) Co., Ltd. Shandong PRC 100.00% Shandong Taibang Biological Products Co., Ltd Shandong PRC 82.] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial and Accounting Officer)]

ONP [Orient Paper] 8-K: CCG Investor Relations Crocker Coulson, President Tel: +1-646-213-1915

[CCG Investor Relations Crocker Coulson, President Tel: +1-646-213-1915 crocker.coulson@ccgir.com Email: Orient Paper, Inc. Winston Yen, Chief Financial Officer Phone: +1-562-818-3817 info@orientpaperinc.com Email: Orient Paper Announces Unaudited Preliminary Results for First Quarter Fiscal Year 2011 BAODING, Hebei, China, May 2, 2011 For the three months ended March 31, 2011, the Company is expecting to report total unaudited revenue increased 25.6% to] [CCG Investor Relations Crocker Coulson, President Tel: +1-646-213-1915 crocker.coulson@ccgir.com Email: Orient Paper, Inc. Winston Yen, Chief Financial Officer Phone: +1-562-818-3817 info@orientpaperinc.com Email: Orient Paper Schedules Conference Call to Discuss 2011 First Quarter Results BAODING, Hebei, China, May 5, 2011 To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call] [Item 2.02. Results of Operations and Financial Condition. Item 8.01.]

CBPO [China Biologic Products] 10-Q/A: FORM 10-Q /A (Amendment No. 1) For the

[FORM 10-Q /A (Amendment No. 1) For the quarterly period ended: June 30, 2010 For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. (Name of Small Business Issuer in Its Charter) DELAWARE 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) No. 14 East Hushan Road, Taian City, Shandong People’s Republic of China 271000] [SUBSIDIARIES China Biologic Products Inc. is the parent. The subsidiaries of China Biologic Products Inc. are as follows: Jurisdiction of Ownership Interest Name Incorporation or Held By Organization The Company Logic Express Ltd BVI 100.00% Logic Holdings (Hong Kong) Ltd HK 100.00% Logic Management Consulting (China) Co., Ltd. Shandong PRC 100.00% Shandong Taibang Biological Products Co., Ltd Shandong PRC 82.] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial and Accounting Officer)]

CNR [CHINA METRO-RURAL] 6-K: (Original Filing)

[China Metro-Rural Holdings Limited CNR Announces Pricing of Units Offering • • If for the fiscal year ended March 31, 2012 the Company’s adjusted EBITDA: ¡ ¡ ¡ The Company has granted the underwriter an option for 45 days to purchase up to an additional 227,696 units. The offering is subject to customary closing conditions and is expected to close] [CHINA METRO-RURAL HOLDINGS LIMITED By Sio Kam Seng]

By | 2016-03-20T09:39:49+00:00 May 6th, 2011|Categories: Chinese Stocks, CNR, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q/A: (Original Filing)

[FORM 10-Q/A (Amendment No. 1) (Mark One) x For the quarterly period ended: March 31, 2010 o For the transition period from ____________ to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of incorporation (I.R.S. Employer Identification No.) or organization) No. 14 East Hushan Road Tai’an City, Shandong 271000 People’s Republic of China (+86) 538-620-2306 (Former name,] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial and Accounting Officer)]

CNR [CHINA METRO-RURAL] 6-K: China Metro-Rural Holdings Limited CNR Announces Pricing of

[China Metro-Rural Holdings Limited CNR Announces Pricing of Units Offering • • If for the fiscal year ended March 31, 2012 the Company’s adjusted EBITDA: ¡ ¡ ¡ The Company has granted the underwriter an option for 45 days to purchase up to an additional 227,696 units. The offering is subject to customary closing conditions and is expected to close] [CHINA METRO-RURAL HOLDINGS LIMITED By Sio Kam Seng]

By | 2016-03-20T09:42:19+00:00 May 6th, 2011|Categories: Chinese Stocks, CNR, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar